AU1189392A - Pharmaceutical agent - Google Patents

Pharmaceutical agent

Info

Publication number
AU1189392A
AU1189392A AU11893/92A AU1189392A AU1189392A AU 1189392 A AU1189392 A AU 1189392A AU 11893/92 A AU11893/92 A AU 11893/92A AU 1189392 A AU1189392 A AU 1189392A AU 1189392 A AU1189392 A AU 1189392A
Authority
AU
Australia
Prior art keywords
pharmaceutical agent
pharmaceutical
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11893/92A
Other languages
English (en)
Inventor
Alan Charles Barker
Robert James Pearce
David Anthony Roberts
Simon Thomas Russell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of AU1189392A publication Critical patent/AU1189392A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU11893/92A 1991-02-08 1992-02-05 Pharmaceutical agent Abandoned AU1189392A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919102727A GB9102727D0 (en) 1991-02-08 1991-02-08 Pharmaceutical agent
GB9102727 1991-02-08

Publications (1)

Publication Number Publication Date
AU1189392A true AU1189392A (en) 1992-09-07

Family

ID=10689748

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11893/92A Abandoned AU1189392A (en) 1991-02-08 1992-02-05 Pharmaceutical agent

Country Status (12)

Country Link
CN (1) CN1064809A (zh)
AP (1) AP9200355A0 (zh)
AU (1) AU1189392A (zh)
CA (1) CA2060825A1 (zh)
GB (2) GB9102727D0 (zh)
HU (1) HUT60489A (zh)
IE (1) IE920243A1 (zh)
IL (1) IL100793A0 (zh)
MX (1) MX9200532A (zh)
PT (1) PT100097A (zh)
WO (1) WO1992013853A1 (zh)
ZA (1) ZA92729B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU656454B2 (en) * 1992-02-14 1995-02-02 E.R. Squibb & Sons, Inc. Biphenyl-substituted quinoline derivatives

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
EP3239170B1 (en) 2008-06-04 2019-03-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP3241839B1 (en) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
EP3004138B1 (en) 2013-06-05 2024-03-13 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase c, method of making and using same
JP6543258B2 (ja) 2013-09-16 2019-07-10 アストラゼネカ アクチボラグ 治療用重合性ナノ粒子とそれを作製して使用する方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
AP161A (en) * 1989-08-11 1991-12-20 Ici Plc Novel Quinoline derivatives.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU656454B2 (en) * 1992-02-14 1995-02-02 E.R. Squibb & Sons, Inc. Biphenyl-substituted quinoline derivatives

Also Published As

Publication number Publication date
IL100793A0 (en) 1992-09-06
IE920243A1 (en) 1992-08-12
PT100097A (pt) 1993-04-30
ZA92729B (en) 1992-11-25
CN1064809A (zh) 1992-09-30
MX9200532A (es) 1992-08-01
GB9102727D0 (en) 1991-03-27
AP9200355A0 (en) 1993-08-03
CA2060825A1 (en) 1992-08-09
HU9200354D0 (en) 1992-04-28
GB9202377D0 (en) 1992-03-18
WO1992013853A1 (en) 1992-08-20
GB2252557A (en) 1992-08-12
HUT60489A (en) 1992-09-28

Similar Documents

Publication Publication Date Title
AU656157B2 (en) Pharmaceutical agents
AU2087992A (en) Pharmaceutical combination formulation
PL304317A1 (en) Pharmaceutical agent
PL304508A1 (en) Pharmaceutical agent
AU3542993A (en) Pharmaceutical compounds
AU1189392A (en) Pharmaceutical agent
AU2392492A (en) Pharmaceutical composition
GB9311030D0 (en) Pharmaceutical formulations
GB9323399D0 (en) Pharmaceutical formulations
AU1500992A (en) Pharmaceutical compound
AU2493792A (en) Pharmaceutical preparation
AU2537992A (en) Pharmaceutical compositions
AU658903B2 (en) Snake-controlling agent
AU1740692A (en) New medicinal use
AU1103092A (en) Immunopotentiating drug
PL297548A1 (en) Pharmaceutical agent
AU7135091A (en) Pharmaceutical composition
AU3528593A (en) Pharmaceutical composition
GB9104124D0 (en) Pharmaceutical agent
GB9104123D0 (en) Pharmaceutical agent
AU8996291A (en) Pharmaceutical formulations
AU673835C (en) Medicinal composition comprising TCF-II
AU6933794A (en) Pharmaceutical formulations
GB9316253D0 (en) Pharmaceutical formulation
GB9315016D0 (en) Pharmaceutical formulation